FDA commissioner watch
This article was originally published in The Gray Sheet
Executive Summary
Massachusetts will be the first state to welcome the not-yet-nominated candidate to head the agency, Sen. Ted Kennedy (D-Mass.) predicts May 11 at the MassMEDIC conference in Waltham, Massachusetts. "I'm looking forward to the time when we finally have our new commissioner of the FDA, and we know that the first stop of that commissioner is going to be in Massachusetts," he says. Kennedy anticipates a close working relationship between the new commissioner and members of the Massachusetts medical device industry council, "the kind of partnership we were beginning to develop - and which I thought made some impressive progress - with our last" commissioner. Jane Henney, VP-Health Sciences at the University of New Mexico, is understood to have been notified the week of March 2 by President Clinton of her selection for the post, although she has yet to be officially nominated pending an FBI background check ("The Gray Sheet" March 16, p. 8). Kennedy encouraged the Administration to select Henney over current Acting Commissioner Michael Friedman...
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.